|
Anavex to present at Rodman & Renshaw Healthcare Conference September 13 in New York Sources News Release
http://www.sources.com/Releases/NR972.htm
Publisher: Dr. Cameron Durrant, MD, MBA, Alzheimer's Disease and Pharmaceuticals/Biot Date Written: 08/09/2010 Year Published: 2010 Resource Type: Article
Anavex Life Sciences Corp. ("ANAVEX") (OTCBB: AVXL) is pleased to announce that Dr. Cameron Durrant, the company#s Executive Chairman, will be presenting at the Rodman & Renshaw 12th Annual Healthcare Conference at 4:45 pm ET on Monday, September 13
Abstract: CALIFON, NJ # September 8, 2010 -- Dr. Cameron Durrant, Executive Chairman of Anavex Life Sciences Corp. (#Anavex#) (OTCBB: AVXL), will be presenting at the Rodman & Renshaw 12th Annual Healthcare Conference at 4:45 pm ET on Monday, September 13, 2010 in New York City. He will discuss ANAVEX 2-73, the company#s lead compound for the treatment of Alzheimer#s disease entering clinical trials, and the business case for Anavex.
Investors can register for free admission by following the instruc... To read the full release go to http://www.sources.com/Releases/NR972.htm
Topics
|
AlterLinks
c/o Sources
© 2025.
|
|
|
|